These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival. Chabot C; Spring K; Gratton JP; Elchebly M; Royal I Mol Cell Biol; 2009 Jan; 29(1):241-53. PubMed ID: 18936167 [TBL] [Abstract][Full Text] [Related]
3. Peptide Lv augments L-type voltage-gated calcium channels through vascular endothelial growth factor receptor 2 (VEGFR2) signaling. Shi L; Ko S; Ko ML; Kim AJ; Ko GY Biochim Biophys Acta; 2015 May; 1853(5):1154-64. PubMed ID: 25698653 [TBL] [Abstract][Full Text] [Related]
4. P300 binds to and acetylates MTA2 to promote colorectal cancer cells growth. Zhou J; Zhan S; Tan W; Cheng R; Gong H; Zhu Q Biochem Biophys Res Commun; 2014 Feb; 444(3):387-90. PubMed ID: 24468085 [TBL] [Abstract][Full Text] [Related]
5. STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen. Ray S; Boldogh I; Brasier AR Gastroenterology; 2005 Nov; 129(5):1616-32. PubMed ID: 16285960 [TBL] [Abstract][Full Text] [Related]
6. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy. Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703 [TBL] [Abstract][Full Text] [Related]
7. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis. Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085 [TBL] [Abstract][Full Text] [Related]
10. YM-359445, an orally bioavailable vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor, has highly potent antitumor activity against established tumors. Amino N; Ideyama Y; Yamano M; Kuromitsu S; Tajinda K; Samizu K; Hisamichi H; Matsuhisa A; Shirasuna K; Kudoh M; Shibasaki M Clin Cancer Res; 2006 Mar; 12(5):1630-8. PubMed ID: 16533791 [TBL] [Abstract][Full Text] [Related]
11. Andrographolide inhibits tumor angiogenesis via blocking VEGFA/VEGFR2-MAPKs signaling cascade. Shen K; Ji L; Lu B; Xu C; Gong C; Morahan G; Wang Z Chem Biol Interact; 2014 Jul; 218():99-106. PubMed ID: 24814888 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress. Illi B; Scopece A; Nanni S; Farsetti A; Morgante L; Biglioli P; Capogrossi MC; Gaetano C Circ Res; 2005 Mar; 96(5):501-8. PubMed ID: 15705964 [TBL] [Abstract][Full Text] [Related]
13. Generation and characterization of a functional Nanobody against the vascular endothelial growth factor receptor-2; angiogenesis cell receptor. Behdani M; Zeinali S; Khanahmad H; Karimipour M; Asadzadeh N; Azadmanesh K; Khabiri A; Schoonooghe S; Habibi Anbouhi M; Hassanzadeh-Ghassabeh G; Muyldermans S Mol Immunol; 2012 Feb; 50(1-2):35-41. PubMed ID: 22208996 [TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling. Huang SW; Lien JC; Kuo SC; Huang TF Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611 [TBL] [Abstract][Full Text] [Related]
15. Characterizing the effects of the juxtamembrane domain on vascular endothelial growth factor receptor-2 enzymatic activity, autophosphorylation, and inhibition by axitinib. Solowiej J; Bergqvist S; McTigue MA; Marrone T; Quenzer T; Cobbs M; Ryan K; Kania RS; Diehl W; Murray BW Biochemistry; 2009 Jul; 48(29):7019-31. PubMed ID: 19526984 [TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38. Lamalice L; Houle F; Jourdan G; Huot J Oncogene; 2004 Jan; 23(2):434-45. PubMed ID: 14724572 [TBL] [Abstract][Full Text] [Related]
17. Lysine acetylation regulates Bruton's tyrosine kinase in B cell activation. Liu Z; Mai A; Sun J J Immunol; 2010 Jan; 184(1):244-54. PubMed ID: 19949111 [TBL] [Abstract][Full Text] [Related]
18. t(8;21) acute myeloid leukaemia cells are dependent on vascular endothelial growth factor (VEGF)/VEGF receptor type2 pathway and phosphorylation of Akt. Imai N; Shikami M; Miwa H; Suganuma K; Hiramatsu A; Watarai M; Satoh A; Itoh M; Imamura A; Mihara H; Nitta M Br J Haematol; 2006 Dec; 135(5):673-82. PubMed ID: 17107349 [TBL] [Abstract][Full Text] [Related]
19. Substrate-specific conformational regulation of the receptor tyrosine kinase VEGFR2 catalytic domain. Solowiej J; Chen JH; Zou HY; Grant SK; Murray BW ACS Chem Biol; 2013 May; 8(5):978-86. PubMed ID: 23441851 [TBL] [Abstract][Full Text] [Related]
20. Acetylation of insulin receptor substrate-1 is permissive for tyrosine phosphorylation. Kaiser C; James SR BMC Biol; 2004 Nov; 2():23. PubMed ID: 15522123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]